Urine DNA biomarkers for hepatocellular carcinoma screening.

Amy K KimJames P HamiltonSelena Y LinTing-Tsung ChangHie-Won HannChi-Tan HuYue LouYih-Jyh LinTerence P GadeGrace ParkHarry LuuTai-Jung LeeJeremy WangDion ChenMichael G GogginsSurbhi JainWei SongYing-Hsiu Su

Published in: British journal of cancer (2022)

Urine ctDNA has promising diagnostic utility in patients in HCC, especially in those with low AFP and can be used as a potential non-invasive HCC screening test.

Keyphrases

end stage renal disease
circulating tumor
ejection fraction
chronic kidney disease
newly diagnosed
single molecule
cell free
risk assessment